Expertise in
14
conditions

Dr. Eric A. Peters

Rheumatology
Arizona Arthritis And Rheumatology Associates
5681 W Beverly Ln Ste 100, 
Glendale, AZ 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
14
conditions
Arizona Arthritis And Rheumatology Associates
5681 W Beverly Ln Ste 100, 
Glendale, AZ 

Overview

Eric Peters is a Rheumatologist practicing medicine in Glendale, Arizona.

Dr. Peters is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Palindromic Rheumatism, Postmenopausal Osteoporosis, and Osteoporosis.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 9 clinical trials. Dr. Peters is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in AZ

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Arizona Arthritis and Rheumatology Associates
5681 W Beverly Ln Ste 100, Glendale, AZ 85306
Other Locations
Arizona Arthritis & Rheumatology Associates P C.
4550 E Bell Rd Ste 172, Phoenix, AZ 85032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

2 Total Publications

Response to: "Interleukin-23 Blockade Is Not Effective in Axial Spondyloarthritis".
Response to: "Interleukin-23 Blockade Is Not Effective in Axial Spondyloarthritis".
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: September 07, 2023
Similar Doctors
Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required
Before you request

Arizona Arthritis And Rheumatology Associates

4550 E Bell Rd Ste 170, 
Phoenix, AZ 
 (10.0 miles away)
480-443-8400
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nehad Soloman is a Rheumatologist practicing medicine in Phoenix, Arizona. Dr. Soloman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Light Chain Deposition Disease (LCDD), IgG4-Related Disease, and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Dr. Soloman is currently accepting new patients.

Expertise in
37
conditions
Dr. Ravi M. Bhalla
Rheumatology
Expertise in
37
conditions
Dr. Ravi M. Bhalla
Rheumatology
Referral may be required
Before you request

Valley Arthritis Care

13613 W Camino Del Sol Ste 4, 
Sun City West, AZ 
 (11.7 miles away)
623-815-2690
Languages Spoken:
English, Hindi, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ravi Bhalla is a Rheumatologist practicing medicine in Sun City West, Arizona. Dr. Bhalla is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Palindromic Rheumatism, Fibromyalgia, Rheumatoid Arthritis (RA), and Osteoporosis. Dr. Bhalla is board certified in American Board Of Internal Medicine. Dr. Bhalla is currently accepting new patients.

Expertise in
35
conditions
Expertise in
35
conditions
Referral required
Before you request

Arthritis Consultants

12665 W Smokey Dr Ste 140, 
Surprise, AZ 
 (9.0 miles away)
623-219-4040
Languages Spoken:
English, Hindi, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Vijayabhanu Mahadevan is a Rheumatologist practicing medicine in Surprise, Arizona. Dr. Mahadevan is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, Osteoporosis, and Rhizomelic Pseudopolyarthritis. Dr. Mahadevan is board certified in American Board Of Internal Medicine. Dr. Mahadevan is currently accepting new patients.

Frequently Asked Questions about Dr. Eric A. Peters

How do I make an appointment with Dr. Eric A. Peters?

You can book an appointment with Dr. Eric A. Peters by calling their office at 480-443-8400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eric A. Peters a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eric A. Peters is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eric A. Peters specialize in?

While Dr. Eric A. Peters is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Palindromic Rheumatism, and Postmenopausal Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Eric A. Peters participate in research or clinical trials?

Yes. Dr. Eric A. Peters has published 2 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Eric A. Peters's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eric A. Peters accept my insurance?

Dr. Eric A. Peters accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 480-443-8400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Peters's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile